Research & Development: Page
-
PharmaVoice Team/PharmaVoice
Clinical Document Development: Planning for Accelerated Timelines
Jean Hosutt, Ph.D., Director, Medical Regulatory Writing Clinical Document Development: Planning for Accelerated Timelines clinical document development Active planning is required to facilitate the partnership between the sponsor and medical-writing contractor resultin...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
November 2003E-media MDS Pharma Express is intuitive, user-friendly, and designed to operate with minimal computer requirements and the highest level of Internet security –providing easy access to current study status information in real time, anytime. MDS Electronic Data-Delivery System Allows f...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Getty Images
TrendlineOncology R&D
Cancer research remains a prime focus for the industry and often leads to pharma’s most impactful breakthroughs.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Site Qualification and Training: Immediate Time, Cost, and Performance Improvements
ePharmaLearning Inc. ePharmaLearning Inc., Conshohocken, Pa., is an industry leading site qualification, clinical e-learning, and site activation company. For more information, visit epharmalearning.com. The keys to improving a clinical trial’s operational success include selecting the b...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Timely Enrollment and Retention: Keys to a Successful Clinical Trial
Ultimately, trial enrollment will always require extensive human interaction between all interested parties. Tools that can facilitate the magic that occurs when new methods of treatment get to market can change lives. Key to a successful clinical trial is timely enrollm...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Clinical Teams Say Sites Can Do Recruitment, But Can They?
Clinical Teams Say Sites Can Do Recruitment, But Can They? Why a fixed budget for every site sets up a study for failure. Patient Recruitment The best strategy is to customize recruitment campaigns to ensure that recruitment is timely and cost-effective. El...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Investigator Initiated Trials: The 800-Pound Gorilla
The Clinical-Trial Process Investigator initiated trials (IITs) can be a significant boon to a company with a new drug or device or sometimes even an older product. Why? Because physicians are engaging in something they truly want to do (it’s their idea, after all), at a cost that’s generally ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
November 18-20, 2003, Westin Copley Place — Boston LogiPharma 2003 This is an opportunity for attendees to hear how competitors and peers are maximizing every facet of their supply-chain strategy. The event provides the opportunity to hear more than 25 confirmed case studies delivered by senior-l...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
On The Cover Flying high on a vision Even as pharmaceutical companies merge to form giant conglomerates, business leaders are choosing to step out on their own and are taking some calculated risks. They embrace the challenges that come with being an entrepreneur and strive to make a difference in...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Letter from the Editor By Taren Grom Editor Driving business forward According to the U.S. Small Business Administration, more than 50% of small businesses fail in the first year and 95% fail within the first five years. Some entrepreneurs describe their decision to set up their own business as a...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's on Your Mind -- Opinions
Opinions What’s on your mind What have you heard lately? In the September issue of PharmaVOICE, we asked readers to relate the most surprising statistics or strange facts that they have come across. PharmaVOICE learned that every human spent about half an hour as a single cell and that 70% of con...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies PMI Appoints Task Force to Oversee CME Compliance Pri-Med Institute (PMI) has named a task force of medical and educational experts to ensure that all of its continuing medical education (CME) programs meet and exceed the new Standards of C...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies E-Media June 2005 PharmaVOICE SAS Upgrades Scientific Discovery Solutions In response to the need for modernization in the drug-development process, SAS Institute Inc. has made significant upgrades and additions to its Scientific ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
June 6-7 Pharmaceutical Marketers KnowledgeShare Forum 2005: Building Brand Differentiation in the Current Regulatory Climate Airport Marriott, Philadelphia This is a PharmaVOICE event, subscribers are eligible for a 15% discount; register using code PVMKS05. For more information, contact Micah L...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
on the cover The time for transparency The government, medical journal editors, and general public are clamoring for the pharmaceutical industry to provide complete information about ongoing and completed clinical trials. There has been a flurry of activity, announcements, and mandates in this ar...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Clinical-Trial Transparency: The Pros and Cons Representing Biotech with David King DTC: The Next Evolution PharmaVOICE www.pharmavoice.com June 2005 Volume 5, Number 6 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Clinical Services: The Evolving Role of the Technology Vendor
The E-Arena etrials Worldwide Inc. With the extensive e-clinical options available to trial sponsors, as well as the continued advancement of technology, there is no question that careful consideration must be given to what tools to employ in clinical-trial research. But choosing a solution d...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Translational Research: Making the Transition from R to D
Translational Research: Making the Transition from R to D There is a growing interest in translational research, which aims to bridge the gap between advances in basic research and the development of safe and effective therapies. June 2005 PharmaVOICE Despite increased investment in research and ...
By Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
CME Programs Accredited by Universities and Societies Receive Preference Continuing medical education (CME) programs created by medical communications agencies achieve a higher level of acceptance among physicians when they are accredited through partnerships with respected university medical sch...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Phase IV Juggernaut: Best Practices for Success
Dimensional HealthCare Inc. Late-stage success depends on an in-depth understanding of the Phase IV scientific drivers, the commercial objectives, and the integration of clinical and marketing knowledge. Adam Serody VP, Clinical Solutions The Phase IV Juggernaut: ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Creating a Guidance System for Life-Science Brands
Creating a Guidance System for Life-Science Brands While meaningful biomedical research depends on proteomics, genetics, and genomics tools, their ultimate application also will depend on successful commercialization and marketing tools. Mark Stinson President ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Recruitment: To Centralize or Decentralize? This is the Question.
Recruitment: To Centralize or Decentralize? This is the Question. Liz Moench President and CEO Patient and Investigator Recruitment In many people’s minds, centralized recruitment often symbolizes big money and big studies. But in actuality, nothing could...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Strategic Phase II Planning -- More Important Than Ever for the Biotech Industry
Strategic Phase II Planning — More Important Than Ever for the Biotech Industry Lukas Makris, Ph.D. CEO Phase II programs should not only be judged on how well the objectives were met, but on how well they might predict the Phase III outcome. The biotechnology industr...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Robust Future for Phase IV Trials
A Robust Future for Phase IV Trials May 2005 VIEW on Biotechnology Clinical Trials Dimensional HealthCare Inc., Cedar Knolls, N.J., designs, implements, and provides community-based research to the pharmaceutical and medical-device industries, focusing on the design and implementation of la...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of contents Letter from the Editor The Forum Biotech: The Perfect Storm — A relatively more favorable funding environment, cutting-edge technologies, and a strong position at the partnership table have many of today’s biotechnology companies in a position for success. Company Listing by Top...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
Society of Hospital Medicine Launches New Medical Journal The Society of Hospital Medicine plans to launch a new peer-reviewed medical journal, The Journal of Hospital Medicine, in 2006. The journal will promote the science and practice of hospital medicine and the enhancement of in-patient care....
By PharmaVoice Team • Jan. 2, 2008
Previous
